查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609615

帕金森氏症的深部脑刺激市场规模、份额和趋势分析报告：按产品、最终用途、按地区、细分市场预测，2025-2030 年

Deep Brain Stimulation In Parkinson's Disease Market Size, Share & Trends Analysis Report By Product (Single-channel, Dual-channel), By End-use (Hospitals, ASCs), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

深部脑部刺激市场的成长和帕金森氏症的趋势：

Grand View Research, Inc.的最新报告显示，到2030年，帕金森氏症脑深部刺激的全球市场规模预计将达到16.1亿美元，2025年至2030年的复合年增长率为10.1%。

帕金森氏症 (PD) 盛行率的快速上升以及人们对帕金森氏症深部脑部刺激的认识不断增强，正在推动市场的发展。

帕金森氏症患者病率的上升推动了对深部脑部刺激作为替代疗法的需求。深部脑部刺激已被证明在为帕金森氏症症状提供治疗解决方案方面发挥关键作用，预计将在预测期内推动市场成长。

此外，由于患者预后改善，对微创治疗的需求不断增长，也是该市场的影响因素。这是因为其成本效益高、痛苦小、安全、住院时间短、恢復快、术后问题少。预计这些主要因素将在预测期内推动对深层脑部刺激器的需求。

此外，主要企业旨在改善术后结果和减少治疗帕金森氏症症状的副作用的技术进步预计也将推动对深部脑部刺激的需求。例如，2020年1月，雅培的Infinity深部脑部刺激系统获得FDA核准，扩大PD治疗适应症。该系统允许患者针对大脑中称为苍白球内部（GPi）的特定区域进行治疗，该区域与帕金森氏症症状相关。

帕金森氏症市场报告的深部脑部刺激亮点

  • 双通道在减少患者震颤方面非常有效，因此越来越多地被神经外科医生采用，到 2024 年将占据市场 56.9% 的份额。
  • 从最终用途来看，医院将在 2024 年占据市场主导地位，因为深部脑部刺激是最复杂、最重要的手术，并且由于拥有高品质和耐用的设备而在医院进行。
  • 由于精神障碍盛行且该地区拥有完善的医疗设施，北美将在 2024 年占据市场主导地位。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章帕金森氏症市场的深部脑部刺激的变数、趋势和范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 营商环境分析
    • 产业分析-波特五力分析
    • PESTLE分析

第四章帕金森氏症市场的深部脑部刺激：产品展望、估计与预测

  • 帕金森氏症的深部脑部刺激市场：2024 年和 2030 年产品变化分析
    • 单通道
    • 双通道

第五章帕金森氏症市场的深部脑部刺激：最终用途展望、估计与预测

  • 帕金森氏症的深部脑部刺激市场：2024 年和 2030 年最终用途变化分析
    • 医院
    • 神经科门诊
    • 门诊手术中心
    • 研究中心

第六章帕金森氏症市场的深部脑部刺激：区域展望、估计与预测

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 2018-2030 年北美市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030 年欧洲市场估计与预测
    • 德国
    • 英国
    • 义大利
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030 年亚太市场估计与预测
    • 中国
    • 日本
    • 印度
    • 印尼
    • 韩国
    • 泰国
    • 澳洲
    • 菲律宾
    • 马来西亚
    • 新加坡
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市场估计与预测
    • 巴西
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 委内瑞拉
  • 中东/非洲
    • 2018-2030 年中东和非洲市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 土耳其
    • 伊朗
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 供应商情况
    • 公司分类
    • 主要经销商及通路伙伴名单
    • 潜在客户/最终用户列表
  • 竞争动态
    • 竞争标基准化分析
    • 策略规划
    • 热图分析
  • 公司简介/名单
    • ABBOTT
    • Medtronic
    • Boston Scientific Corporation
Product Code: GVR-4-68038-749-0

Deep Brain Stimulation In Parkinson's Disease Market Growth & Trends:

The global deep brain stimulation in Parkinson's disease market size is anticipated to reach USD 1.61 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.1% from 2025 to 2030. Surge in the incidence of Parkinson's Disease (PD) and growing awareness about the deep brain stimulation in PD are driving the market.

Rising prevalence of Parkinson's disease has raised the demand for deep brain stimulators as an alternative therapy. Deep brain stimulation has been proved to play an important role in providing therapeutic solutions for the symptoms of Parkinson's disease, which is expected to fuel the market growth during the forecast period.

Moreover, increasing demand for minimally invasive therapies due to improved patient outcomes is a high impact rendering driver for this market. This is due to high cost efficiency, minimal pain, safety, short duration of hospital stays, speedy recovery, and few cases of post-surgical problems. These key factors are anticipated to raise the demand for deep brain stimulators over the forecast period.

In addition, technological advancements by the key players for the improved postoperative outcomes and reduced adverse effects in the treatment of PD symptoms are anticipated to raise the demand for deep brain stimulation. For instance, in January 2020, Abbott's Infinity deep brain stimulation system has secured expanded indication approval from the FDA for the treatment of PD. This system will allow to target patients' specific area of the brain called internal globus pallidus (GPi), which is associated with Parkinson's disease symptoms.

Deep Brain Stimulation In Parkinson's Disease Market Report Highlights:

  • The dual channel segment dominated the market with the share of 56.9% in 2024 owing to its increasing adoption by neurosurgeons as it is highly effective in reducing patient tremors
  • On the basis of end-use, hospitals dominated the market in 2024 since deep brain stimulation procedures are the most complicated and critical surgeries that are performed in hospitals due to availability of high quality and durable equipment
  • North America dominated the market with in 2024 owing to prevalence of psychological disorders and presence of well-established healthcare facilities in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Insights
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. Deep Brain Stimulation In Parkinson's Disease Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Deep Brain Stimulation In Parkinson's Disease Market: Product Outlook Estimates & Forecasts

  • 4.1. Deep Brain Stimulation In Parkinson's Disease Market: Product Movement Analysis, 2024 & 2030
    • 4.1.1. Single-channel
      • 4.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.1.2. Dual-channel
      • 4.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Deep Brain Stimulation In Parkinson's Disease Market: End Use Outlook Estimates & Forecasts

  • 5.1. Deep Brain Stimulation In Parkinson's Disease Market: End Use Movement Analysis, 2024 & 2030
    • 5.1.1. Hospitals
      • 5.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.1.2. Neurology Clinics
      • 5.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.1.3. Ambulatory Surgical Centers
      • 5.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.1.4. Research Centers
      • 5.1.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Deep Brain Stimulation In Parkinson's Disease Market Regional Outlook Estimates & Forecasts

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework
      • 6.4.2.3. Competitive insights
      • 6.4.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework
      • 6.4.3.3. Competitive insights
      • 6.4.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework
      • 6.4.4.3. Competitive insights
      • 6.4.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive insights
      • 6.5.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. UK
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive insights
      • 6.5.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework
      • 6.5.4.3. Competitive insights
      • 6.5.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. France
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework
      • 6.5.5.3. Competitive insights
      • 6.5.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Italy
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework
      • 6.5.6.3. Competitive insights
      • 6.5.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Spain
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework
      • 6.5.7.3. Competitive insights
      • 6.5.7.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework
      • 6.5.8.3. Competitive insights
      • 6.5.8.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key country dynamics
      • 6.5.9.2. Regulatory framework
      • 6.5.9.3. Competitive insights
      • 6.5.9.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.10. Norway
      • 6.5.10.1. Key country dynamics
      • 6.5.10.2. Regulatory framework
      • 6.5.10.3. Competitive insights
      • 6.5.10.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive insights
      • 6.6.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Japan
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive insights
      • 6.6.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive insights
      • 6.6.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Indonesia
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive insights
      • 6.6.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive insights
      • 6.6.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive insights
      • 6.6.7.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.8. Australia
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework
      • 6.6.8.3. Competitive insights
      • 6.6.8.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.9. Philippines
      • 6.6.9.1. Key country dynamics
      • 6.6.9.2. Regulatory framework
      • 6.6.9.3. Competitive insights
      • 6.6.9.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.10. Malaysia
      • 6.6.10.1. Key country dynamics
      • 6.6.10.2. Regulatory framework
      • 6.6.10.3. Competitive insights
      • 6.6.10.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.11. Singapore
      • 6.6.11.1. Key country dynamics
      • 6.6.11.2. Regulatory framework
      • 6.6.11.3. Competitive insights
      • 6.6.11.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive insights
      • 6.7.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive insights
      • 6.7.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. Colombia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework
      • 6.7.4.3. Competitive insights
      • 6.7.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. Chile
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework
      • 6.7.5.3. Competitive insights
      • 6.7.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.6. Venezuela
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework
      • 6.7.6.3. Competitive insights
      • 6.7.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. Middle East & Africa
    • 6.8.1. MEA market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive insights
      • 6.8.2.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework
      • 6.8.3.3. Competitive insights
      • 6.8.3.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework
      • 6.8.4.3. Competitive insights
      • 6.8.4.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Turkey
      • 6.8.5.1. Key country dynamics
      • 6.8.5.2. Regulatory framework
      • 6.8.5.3. Competitive insights
      • 6.8.5.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.6. Iran
      • 6.8.6.1. Key country dynamics
      • 6.8.6.2. Regulatory framework
      • 6.8.6.3. Competitive insights
      • 6.8.6.4. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.7. Kuwait
      • 6.8.7.1. Key country dynamics
      • 6.8.7.2. Regulatory framework
      • 6.8.7.3. Competitive insights
      • 6.8.7.4. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Vendor Landscape
    • 7.2.1. Company categorization
    • 7.2.2. List of Key Distributors and Channel Partners
    • 7.2.3. List of Potential Customers/End Users
  • 7.3. Competitive Dynamics
    • 7.3.1. Competitive Benchmarking
    • 7.3.2. Strategy Mapping
    • 7.3.3. Heat Map Analysis
  • 7.4. Company Profiles/Listing
    • 7.4.1. ABBOTT
      • 7.4.1.1. Participant's overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Medtronic
      • 7.4.2.1. Participant's overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Boston Scientific Corporation
      • 7.4.3.1. Participant's overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives

List of Tables

  • Table 1. List of abbreviations
  • Table 2. Deep brain stimulation in Parkinson's disease market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
  • Table 3. Deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 4. Deep brain stimulation in Parkinson's disease market estimates and forecasts, by region, 2018 - 2030 (USD Million)
  • Table 5. North America deep brain stimulation in Parkinson's disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 6. North America deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 7. North America deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 8. U.S. deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 9. U.S. deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 10. Canada deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 11. Canada deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 12. Mexico deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 13. Mexico deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 14. Europe deep brain stimulation in Parkinson's disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 15. Europe deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 16. Europe deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 17. UK deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 18. UK deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 19. Germany deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 20. Germany deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 21. France deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 22. France deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 23. Italy deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 24. Italy deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 25. Spain deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 26. Spain deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 27. Denmark deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 28. Denmark deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 29. Sweden deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 30. Sweden deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 31. Norway deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 32. Norway deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific deep brain stimulation in Parkinson's disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 36. Japan deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 37. Japan deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 38. China deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 39. China deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 40. India deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 41. India deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 42. Indonesia deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 43. Indonesia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 44. South Korea deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 45. South Korea deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 46. Thailand deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 47. Thailand deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 48. Australia deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 49. Australia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 50. Philippines deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 51. Philippines deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 52. Malaysia deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 53. Malaysia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 54. Singapore deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 55. Singapore deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 56. Latin America deep brain stimulation in Parkinson's disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 57. Latin America deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 58. Latin America deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 59. Brazil deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 60. Brazil deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 61. Argentina deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 62. Argentina deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 63. Colombia deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 64. Colombia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 65. Chile deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 66. Chile deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 67. Venezuela deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 68. Venezuela deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 69. Middle East & Africa deep brain stimulation in Parkinson's disease market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 70. Middle East & Africa deep brain stimulation in Parkinson's disease market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 71. Middle East & Africa deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 72. South Africa deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 73. South Africa deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 74. Saudi Arabia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 75. Saudi Arabia deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 76. UAE deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 77. UAE deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 78. Turkey deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 79. Turkey deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 80. Iran deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 81. Iran deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 82. Kuwait deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 83. Kuwait deep brain stimulation in Parkinson's disease market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Market snapshot
  • Fig. 6 Segmental outlook- Product, and End Use
  • Fig. 7 Competitive outlook
  • Fig. 8 Value chain analysis
  • Fig. 9 Market dynamics
  • Fig. 10 Porter's analysis
  • Fig. 11 PESTEL analysis
  • Fig. 12 Deep brain stimulation In Parkinson's disease market, by product: Key takeaways
  • Fig. 13 Deep brain stimulation In Parkinson's disease market, by product: Market share, 2024 & 2030
  • Fig. 14 Deep brain stimulation In Parkinson's disease market, by end use: Key takeaways
  • Fig. 15 Deep brain stimulation In Parkinson's disease market, by end use: Market share, 2024 & 2030
  • Fig. 16 Deep brain stimulation In Parkinson's disease market, by region: Key takeaways
  • Fig. 17 Deep brain stimulation In Parkinson's disease market, by region: Market share, 2024 & 2030